Therapeutic results of intra-arterial chemotherapy in patients with malignant glioma

International Journal of Oncology

Volumn 13, Issue 3, 1998, Pages 537-542

  Hirano, Yoshitaka ^a   Mineura, Katsuyoshi ^a   Mizoi, Kazuo ^a   Tomura, Noriaki ^a  

^a AKITA UNIVERSITY HOSPITAL   (Japan)

Author keywords

ACNU (nimustine hydrochloride); Intra arterial chemotherapy; Karnofsky's performance status; Malignant glioma; Survival analysis

Indexed keywords

NIMUSTINE;

ADULT; ARTICLE; ASTROCYTOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; SKIN MANIFESTATION; VOMITING;

EID: 0031824254     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.3.537     Document Type: Article

References (38)

1. Chauveinc L, Sola-Martinez MT, Martin-Duverneuil M, Mazeron JJ, Faillot T, Cornu P, Capelle L, Delattre JY, Poisson M, Baillet F and Chiras J: Intra arterial chemotherapy with ACNU and radiotherapy in inoperable malignant gliomas. J Neurooncol 27: 141-147, 1996.
2. Mineura K, Watanabe K, Kowada M and Kato T: Malignant gliomas treated with split course radiotherapy plus chemotherapy. Int J Oncol 2: 457-461, 1993.
3. Stewart DJ, Grahovac Z, Hugenhpltz H, Russell N, Richard M and Benoit B: Combined intraarterial and systemic chemotherapy for intracerebral tumors. Neurosurgery 21: 207-214, 1987.
4. Watne K, Nome O, Hager B and Hirschberg H: Combined intraarterial chemotherapy and irradiation of malignant gliomas. Acta Oncol 30: 835-841, 1991.
5. Boiardi A, Silvani A, Pozzi A, Farinotti M, Fariselli L, Broggi G and Salmaggi A: Advantage of treating anaplastic gliomas with aggressive protocol combining chemotherapy and radiotherapy. J Neurooncol 34: 179-185, 1997.
6. Hori T, Muraoka K, Saito Y, Sasahara K, Inagaki H, Inoue Y, Adachi S and Anno Y: Influence of modes of ACNU administration on tissue and blood drug concentration in malignant brain tumors. J Neurosurg 66: 372-378, 1987.
7. Shapiro WR, Green SB, Burger PC, Selker RG, van Gilder JC, Robertson JT, Mealey J, Ransohoff J and Mahaley MS Jr: A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 76: 772-781, 1992.
8. 11C]BCNU evaluated by PET. J Nucl Med 27: 775-780, 1986.
9. Hiesiger E, Green SB, Shapiro WR, Burger PC, Selker RG, Mahaley MS Jr, Ransohoff J II, van Gilder JC, Mealey J, Robertson JT, Hochberg FH and Young RF: Results of a randomized trial comparing intra-arterial cisplatin and intravenous PCNU for the treatment of primary brain tumors in adults: Brain Tumor Cooperative Group trial 8420A. J Neurooncol 25: 143-154, 1995.
10. Iwadate Y, Namba H and Sueyoshi K: Intra-arterial ACNU and cisplatin chemotherapy for the treatment of glioblastoma multiforme. Neurol Med Chir (Tokyo) 35: 598-603, 1995.
11. Lesser GJ and Grossman SA: The chemotherapy of adult primary brain tumors. Cancer Treat Rev 19: 261-281, 1993.
12. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET and Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5: 649-655, 1982.
13. Donovan K, Sanson-Fisher RW and Redman S: Measuring quality of life in cancer patients. J Clin Oncol 7: 959-968, 1989.
14. Giovagnoli AR, Tamburini M and Boiardi A: Quality of life in brain tumor patients. J Neurooncol 30: 71-80, 1996.
15. Schipper H, Clinch J, McMurray A and Levitt M: Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. J Clin Oncol 2: 472-483, 1984.
16. Spielberger CD, Gorsuch RL and Lushene RE: Manual for the State-Trait Anxiety Inventory. Consulting Psychologist Press, Palo Alto, California, 1970.
17. Zung WWK: A self-rating depression scale. Arch Gen Psychiat 12: 63-70, 1965.
18. Belanich M, Pastor M, Randall T, Guerra D, Kibitel J, Alas L, Li B, Citron M, Wasserman P, White A, Eyre H, Jaeckle K, Schulman S, Rector D, Prados M, Coons S, Shapiro W and Yarosh D: Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine. Cancer Res 56: 783-788, 1996.
19. Kiwit JCW, Floeth FW and Bock WJ: Survival in malignant glioma: Analysis of prognostic factors with special regard to cytoreductive surgery. Zentralbl Neurochir 57: 76-88, 1996.
20. Phuphanich S, Ferrall S and Greenberg H: Long-term survival in malignant glioma. Prognostic factors. J Fla Med Assoc 80: 181-184, 1993.
21. Watne K, Hannisdal E, Nome O, Hager and Hirschberg H: Prognostic factors in malignant gliomas with special reference to intra-arterial chemotherapy. Acta Oncol 32: 307-310, 1993.
22. Whittle IR, Denholm SW and Gregor A: Management of patients aged over 60 years with supratentorial glioma: Lessons from an audit. Surg Neurol 36: 106-111, 1991.
23. Kleihues P, Burger PC and Scheinthauer BW: Histopathological typing of tumours of the central nervous system. 2nd edition. Springer-Verlag, Berlin, 1993.
24. Murray KJ, Nelson DF, Scott C, Fischbach AJ, Porter A, Faman N and Curran WJ Jr Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: A report of Radiation Therapy Oncology Group (RTOG) 83-02. Int J Radiat Oncol Biol Phys 31: 453-459, 1995.
25. Sachsenheimer W, Piotrowski W and Bimmler T: Quality of life in patients with intracranial tumors on the basis of Karnofsky's performance status. J Neurooncol 13: 177-181, 1992.
26. Flowers A and Levin VA: Chemotherapy for brain tumors. In: Brain Tumors. Kaye AH, Jaws ER Jr (eds.) Churchill Livingstone, pp349-360, 1995.
27. Takamura K, Abe H, Tanaka R, Kitamura K, Miwa T, Takeuchi K, Yamamoto S, Kageyama N, Handa H, Mogami H, Nishimoto A, Uozumi T, Matsutani M and Nomura K: Effects of ACNU and radiotherapy on malignant glioma. J Neurosurg 64: 53-57, 1986.
28. 6-methylguanine-deoxyribonucleic acid methyltransferase messenger ribonucleic acid for therapy of malignant gliomas. Neurosurgery 41: 434-441, 1997.
29. 6-methylguanine-DNA methyltransferase in mammalian cells. Cancer Res 52: 1804-1809, 1992.
30. 6-alkylguaine-DNA alkyltransferase protects against some of the biological effects of N-methyl-N′-nitro-N-nitrosoguanidine in C3H 10T1/2 cells. Radiat Res 127: 220-225, 1991.
31. Bauman GS, Gasper LE, Fisher BJ, Halperin EC, Macdonald DR and Cairncross JG: A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys 29: 835-839, 1994.
32. Brazil L, Thomas R, Laing R, Hines F, Guerrero D, Ashley S and Brada M: Verbally administered Barthel Index as functional assessment in brain tumor patients. J Neurooncol 34: 187-192, 1997.
33. Hoegler DB and Davey P: A prospective study of short course radiotherapy in elderly patients with malignant glioma. J Neurooncol 33: 201-204, 1997.
34. Karnofsky DA, Abelmann WH, Graver LF and Burchenal JH: The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer 1: 634-656, 1948.
35. Milstein JM, Cohen ME and Sinks LF: The influence and reliability of neurologic assessment and Karnofsky Performance Score on prognosis. Cancer 56: 1834-1836, 1985.
36. Watne K, Hannisdal E, Nome O, Hager B and Hirschberg H: Combined intra-arterial and systemic chemotherapy for recurrent malignant brain tumors. Neurosurgery 30: 223-227, 1992.
37. Glantz MJ, Choy H, Kearns CM, Akerley W and Egorin MJ: Weekly, outpatient paclitaxel and concurrent cranial irradiation in adults with brain tumors: preliminary results and promising directions. Semin Oncol 22 (Suppl 12): 26-32, 1995.
38. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohr G, Muller P, Morawetz R and Schold SC: Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 345: 1008-1012, 1995.